These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28157165)

  • 1. Stem Cell Therapies in Retinal Disorders.
    Garg A; Yang J; Lee W; Tsang SH
    Cells; 2017 Feb; 6(1):. PubMed ID: 28157165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD).
    Fields M; Cai H; Gong J; Del Priore L
    Cells; 2016 Dec; 5(4):. PubMed ID: 27941641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for retinal cell generation from human pluripotent stem cells.
    Weed LS; Mills JA
    Stem Cell Investig; 2017; 4():65. PubMed ID: 28815176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of Induced Pluripotent Stem Cells as Regenerative Medicine in Retinal Cell Damage.
    Sun YJ; Pan YR; Fan B; Li GY
    J Environ Pathol Toxicol Oncol; 2018; 37(4):305-316. PubMed ID: 30806237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
    Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
    J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell transplantation to replace retinal ganglion cells faces challenges - the Switchboard Dilemma.
    Liu Y; Lee RK
    Neural Regen Res; 2021 Jun; 16(6):1138-1143. PubMed ID: 33269762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
    Leach LL; Clegg DO
    Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent human stem cells for the treatment of retinal disease.
    Rowland TJ; Buchholz DE; Clegg DO
    J Cell Physiol; 2012 Feb; 227(2):457-66. PubMed ID: 21520078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current focus of stem cell application in retinal repair.
    Alonso-Alonso ML; Srivastava GK
    World J Stem Cells; 2015 Apr; 7(3):641-8. PubMed ID: 25914770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration.
    Parameswaran S; Balasubramanian S; Babai N; Qiu F; Eudy JD; Thoreson WB; Ahmad I
    Stem Cells; 2010 Apr; 28(4):695-703. PubMed ID: 20166150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in iPSC technologies involving cardiovascular and neurodegenerative disease modeling.
    Csöbönyeiová M; Danišovič Ľ; Polák Š
    Gen Physiol Biophys; 2016 Jan; 35(1):1-12. PubMed ID: 26492069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPSCs, aging and age-related diseases.
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of retinal cells from mouse and human induced pluripotent stem cells.
    Hirami Y; Osakada F; Takahashi K; Okita K; Yamanaka S; Ikeda H; Yoshimura N; Takahashi M
    Neurosci Lett; 2009 Jul; 458(3):126-31. PubMed ID: 19379795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
    Li Y; Chan L; Nguyen HV; Tsang SH
    Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.